TLR4 and neurodegenerative disease: Therefore, our results indicate that Mn3O4 nanozymes can not only inhibit LPS-induced TLR4 upregulation, but also promote the transition of microglia from M1 to M2 phenotype, thus highlighting its neuroprotective potential and therapeutic applicability in neurodegenerative diseases.